Page last updated: 2024-08-21

methysergide and Angor Pectoris

methysergide has been researched along with Angor Pectoris in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19902 (50.00)18.7374
1990's2 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gelford, GJ; Kroll, LL; Nelson, D; Wilets, AJ1
Foster, JB; Hudgson, P; Walton, JN1
Bax, WA; Ferrari, MD; MaassenVanDenBrink, A; Reekers, M; Saxena, PR1
Barraud, P; Cassagnes, J; Fichter, P; Fournier, E; Grand, A; Lusson, JR; Shibli, H1

Reviews

1 review(s) available for methysergide and Angor Pectoris

ArticleYear
[Vasospastic angina with angiographically normal coronary vessels of iatrogenic origin. Apropos of 2 cases].
    Annales de cardiologie et d'angeiologie, 1992, Volume: 41, Issue:1

    Topics: Adult; Angina Pectoris; Coronary Vasospasm; Drug Therapy, Combination; Ergotamine; Female; Humans; Iatrogenic Disease; Male; Methylergonovine; Methysergide; Middle Aged

1992

Other Studies

3 other study(ies) available for methysergide and Angor Pectoris

ArticleYear
Retroperitoneal fibrosis and methsergide. Report of three cases.
    Radiology, 1967, Volume: 88, Issue:5

    Topics: Adult; Angina Pectoris; Female; Humans; Male; Methysergide; Middle Aged; Retroperitoneal Fibrosis; Ureteral Obstruction; Urinary Catheterization; Urography

1967
Methysergide and coronary artery disease.
    American heart journal, 1967, Volume: 74, Issue:6

    Topics: Adult; Angina Pectoris; Coronary Disease; Female; Humans; Male; Methysergide; Myocardial Infarction; Retroperitoneal Fibrosis

1967
Coronary side-effect potential of current and prospective antimigraine drugs.
    Circulation, 1998, Jul-07, Volume: 98, Issue:1

    Topics: Adolescent; Adult; Aged; Angina Pectoris; Child; Coronary Vessels; Dihydroergotamine; Ergotamine; Female; Humans; In Vitro Techniques; Indoles; Male; Methysergide; Middle Aged; Migraine Disorders; Piperidines; Sulfonamides; Sumatriptan; Triazoles; Tryptamines; Vasoconstrictor Agents

1998